STXS (Stereotaxis) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


STXS Stereotaxis Inc STXS
66 GF Score
Price $1.63
GF Value $2.31
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Stereotaxis Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Stereotaxis's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

STXS vs EMBC, KRMD, PDEX: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stereotaxis Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Margin of Safety % (DCF FCF Based) falls into.


STXS
66GF Score
Stereotaxis Inc STXS
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Stereotaxis (STXS) Overvalued in 2026?

Based on GuruFocus' analysis, Stereotaxis stock appears to be undervalued. The current stock price of $1.63 is trading 29.4% below its estimated GF Value™ of $2.31. GuruFocus considers Stereotaxis to be Modestly Undervalued.

Key valuation signals for STXS:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: $2.31 vs. price of $1.63 (29.4% below fair value)
  • GF Score™: 66/100 with 4 warning signs

No single metric tells the full story. See the STXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stereotaxis Business Description

Other Exchanges RJR1:Germany
Address 710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
66GF Score

Get the complete analysis for STXS

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.63
Price
$2.31
GF Value